CGP 42934
Latest Information Update: 30 May 2001
At a glance
- Originator Novartis
- Class Plasminogen activator enzymes; Thrombolytics
- Mechanism of Action Plasminogen activators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Ischaemic heart disorders; Thrombosis
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 04 Nov 1997 No-Development-Reported for Ischaemic heart disorders in Italy (Unknown route)
- 04 Nov 1997 No-Development-Reported for Thrombosis in Italy (Unknown route)